PULMONARY ARTERIAL HYPERTENSION
Clinical trials for PULMONARY ARTERIAL HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERIAL HYPERTENSION trials appear
Sign up with your email to follow new studies for PULMONARY ARTERIAL HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could ease strain on Lungs' blood vessels
Disease control Not yet recruitingThis study tests an oral medication called NS-863 in people with pulmonary arterial hypertension (PAH), a condition where blood vessels in the lungs narrow, making the heart work harder. About 135 adults will receive either NS-863 or a placebo for 24 weeks to see if the drug impr…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated May 17, 2026 00:28 UTC
-
New inhaled drug aims to help PAH patients walk farther
Disease control Not yet recruitingThis study tests a new inhaled powder called treprostinil palmitil (TPIP) taken once daily to see if it helps people with pulmonary arterial hypertension (PAH) walk farther. About 344 adults with PAH will receive either TPIP or a placebo for 24 weeks. The main goal is to measure …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could a new drug ease the strain on hearts of PAH patients?
Disease control Not yet recruitingThis early-stage study tests a drug called 2-HOBA in 12 adults with pulmonary arterial hypertension (PAH), a condition where high blood pressure damages the lungs and heart. The goal is to see if the drug can improve heart function and reduce signs of disease. Participants must b…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Can a simple medication switch improve outcomes for PAH patients?
Knowledge-focused Not yet recruitingThis study reviews medical records of 15 adults with pulmonary arterial hypertension (PAH) who switched from one medication to riociguat while on triple therapy. The goal is to see if the switch improves walking distance, symptoms, and blood markers at 6 months. No new treatments…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Sponsor: Caio Júlio César dos Santos Fernandes • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Sleep breathing problems linked to heart risk in lung disease patients
Knowledge-focused Not yet recruitingThis study follows 60 adults with pulmonary hypertension to see how sleep-related breathing issues and heart rate patterns evolve over two years. Participants will have overnight sleep tests at the start, 12 months, and 24 months. The goal is to find better ways to predict and ma…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated May 11, 2026 20:51 UTC